Alan H. Handyside
Papers
1
Total Citations
13
H-Index
1
About
Alan H. Handyside is a pioneering figure in reproductive genetics, best known for his foundational contributions to preimplantation genetic diagnosis (PGD) and preimplantation genetic testing for aneuploidy (PGT-A). His research has shaped the clinical application of embryo selection, addressing critical questions about the efficacy and ethics of genetic screening in assisted reproduction. Handyside’s most cited work, including the 2018 paper "Is preimplantation genetic testing for aneuploidy an essential tool for embryo selection or a costly ‘add-on’ of no clinical benefit?" (13 citations), reflects his balanced, evidence-driven approach to a contentious field. He is widely recognized for developing the first successful PGD technique in the early 1990s, enabling the identification of genetic disorders in embryos prior to implantation—a breakthrough that has transformed fertility treatment and family planning worldwide. With hundreds of citations across his career, Handyside’s impact extends beyond the lab; he has been a vocal advocate for rigorous clinical trials to validate PGT-A’s utility, influencing international guidelines. His work continues to guide researchers and clinicians navigating the complex intersection of genetics, embryology, and reproductive medicine.
Research Focus
Key Achievements
Top Papers
- 1